Illumina, Inc. Share Price & Technical Analysis
ILMN · $145.7 (+0.89%)
Healthcare / Diagnostics & Research
$145.7
+0.89%
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and c…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
8% return in May, -4% avg return in past 3 year May month.
9% return in 2026, 4% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 10% | -6% | -6% | 3% | 8% | – | – | – | – | – | – | – | 9% |
| 25 | -1% | -31% | -11% | -2% | 6% | 17% | 8% | 8% | -4% | 30% | 9% | 1% | 29% |
| 24 | 4% | -3% | -1% | -11% | -15% | 3% | 18% | 7% | -1% | 11% | 0% | -7% | 5% |
| 23 | 5% | -6% | 17% | -11% | -4% | -4% | 2% | -13% | -19% | -20% | -6% | 37% | -22% |
| 22 | -8% | -7% | 7% | -16% | -19% | -23% | 18% | -6% | -5% | 18% | -5% | -7% | -53% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$21.71B
P/E ratio
26.09
52W high
$155.5
52W low
$78.79
Volume
6,32,767
Beta
1.42
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Illumina, Inc. share price today?
- Illumina, Inc. (ILMN) last traded around $145.7 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ILMN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ILMN. Download the app for real-time alerts.
- How can I analyze Illumina, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.